SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-242705
Filing Date
2018-08-08
Accepted
2018-08-08 16:03:21
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d543555d10q.htm 10-Q 752854
2 EX-31.1 d543555dex311.htm EX-31.1 6248
3 EX-31.2 d543555dex312.htm EX-31.2 6242
4 EX-32.1 d543555dex321.htm EX-32.1 4830
  Complete submission text file 0001193125-18-242705.txt   4116728

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20180630.xml EX-101.INS 600748
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20180630.xsd EX-101.SCH 45185
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20180630_cal.xml EX-101.CAL 43239
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20180630_def.xml EX-101.DEF 235133
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20180630_lab.xml EX-101.LAB 390052
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20180630_pre.xml EX-101.PRE 315194
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 181001309
SIC: 2834 Pharmaceutical Preparations